Wellness & Lifestyle

CureMetrix is an AI-powered platform dedicated to advancing technology for improved disease detection and cancer survival rates globally. The tool empowers radiologists by providing advanced technology to support their evaluation of mammograms, aiming for better clinical and financial outcomes. Key offerings include cmAngio®, cmAssist®, cmTriage®, and cmDensity™. CureMetrix focuses on reducing false positive rates to minimize unnecessary follow-up procedures and patient anxiety, increasing early detection of microscopic changes, and improving the evaluation of dense breast tissue. The platform also helps track treatment response over time and enhances clinical efficiency by prioritizing suspicious anomalies.

Aiosyn specializes in AI-powered pathology software, focusing on cancer and chronic kidney disease biomarkers. Their solutions improve digital pathology workflows and facilitate informed decision-making in drug development and clinical diagnostics. Key offerings include AiosynQC for automated quality control of digital histology slides, Aiosyn Mitosis Breast for identifying mitotic figures in breast H&E sections, and the NephroPath platform for precise quantification of kidney lesion scores. Aiosyn also provides services like external digital slide quality assessments and kidney image analysis, supporting pathology labs and biopharma with consistent and efficient analyses without requiring complex integration.

DIGESTAID is an AI platform dedicated to advancing digestive healthcare through innovative deep learning solutions. It specializes in the automatic detection and characterization of digestive lesions, providing critical support for physicians in their decision-making processes. The tool encompasses a wide scope of applications, including non-invasive capsule endoscopy technologies, AI live vision for procedures like cholangioscopy and endoscopic ultrasound, and digestive motility and raw data analysis technologies for anorectal and esophageal manometry. DIGESTAID aims to improve diagnostic accuracy and workflow efficiency, leveraging a combination of gastroenterological expertise and advanced engineering to deliver accurate and impactful AI solutions.

SymptomChecker.io offers an AI-powered platform for users to describe their medical symptoms and receive AI-generated evaluations. Users can input details such as age, gender, main symptoms, their severity, changes over time, what makes them better or worse, recent illnesses or travel history, relevant health issues, surgeries, social history, current medications, and relevant test results. The tool is presented as a student-made experimental project to explore the potential of AI in healthcare. It explicitly states that it is not intended to offer medical advice, diagnosis, or treatment, and should not be used as a substitute for professional medical consultation.

Digital Diagnostics pioneers AI-driven healthcare, offering FDA-cleared diagnostic tools that enhance clinical accuracy and improve patient outcomes. Their flagship product, LumineticsCore®, is the first autonomous AI for diabetic retinopathy, capable of diagnosing the condition at the point-of-care without physician input. This technology helps increase patient access to specialty services, expedites referrals, and prevents vision loss through early detection. The company is committed to ethical AI and expanding its research into other conditions like glaucoma, cardiovascular indications, AMD, and neurodegenerative indications, aiming to make healthcare more accessible, affordable, and equitable worldwide.

egnite Health offers the CardioCare platform, a digital health solution that utilizes artificial intelligence-driven algorithms to generate business intelligence for healthcare. The platform is designed to identify and improve outcomes for cardiovascular patients in the U.S. by analyzing large datasets. CardioCare supports progressive cardiovascular centers with solutions across valve disease, heart failure, and atrial fibrillation, and also aids in clinical trials. For life sciences, egnite provides the Therapy Accelerator & Research, offering access to one of the largest ecosystems of real-world cardiovascular data. The platform aims to enhance human intelligence with AI to guide critical decisions in healthcare, ultimately advancing the cardiovascular health of society.

MediScoper is an AI-assisted platform designed for healthcare professionals to streamline doctor-patient interactions. It offers accurate audio transcription, automated analysis reports aligned with SOAP standards, and real-time diagnostic proposals powered by cutting-edge AI. The platform supports translations in over 60 languages, bridging communication gaps. MediScoper prioritizes data security with anonymous processing, state-of-the-art encryption, and GDPR compliance, ensuring patient confidentiality. It aims to reduce administrative burdens, allowing healthcare providers to focus more on patient care. The tool also integrates seamlessly into existing systems by outputting standard documentation for EHRs, enhancing workflow efficiency.

Emobot is a MedTech startup developing a medical device for the continuous detection and monitoring of mood disorders, including depression and anxiety. Utilizing AI, Emobot analyzes emotional expressions through facial recognition and voice analysis to track mood changes over time. The platform offers two main products: EmoDTx, a digital therapy, and EmoCare, a diagnostic tool. These tools aim to empower patients, improve diagnostic accuracy and care efficiency for doctors, and enhance drug development and clinical trials for pharmaceutical companies by providing objective, continuous mood data. Emobot's technology creates an emotional 'heat map' to summarize a person's emotional tone throughout the day, offering a novel approach to mental health monitoring.

ThakaaMed is dedicated to transforming healthcare through AI-powered precision, offering advanced medical intelligence solutions. The platform provides AI-assisted diagnostics for a wide range of healthcare applications, including Dental IQ for dental diagnostics and treatment planning, Stroke IQ for faster, accurate neuroimaging diagnoses, and Chest IQ for chest X-ray analysis. ThakaaMed also features an A.I. Factory for end-to-end workflow-powered medical data labeling. The tool emphasizes five pillars: Probative (evidence-based care), Predictive (foreseeing health issues), Preventive (proactive monitoring), Personalized (tailored care), and Participatory (engaging patients). It aims to enhance precision, reduce errors, and improve patient outcomes across various medical specialties.

Duniya Health is an AI-powered platform designed to transform cancer care management for both patients and caregivers. It provides a comprehensive solution for tracking symptoms, managing medications, and organizing appointments, simplifying the complex cancer journey. The platform includes an AI Companion for personalized medical advice and a Care Circle Platform to facilitate caregiver support. Additionally, it offers tools for diet and nutrition planning specifically tailored for cancer patients. Duniya Health aims to unify fragmented patient management tools, empowering individuals to achieve better outcomes through AI-driven health solutions.

SafeBeat Rx is a software platform designed to revolutionize cardiac therapeutics by leveraging advanced AI and mobile technology. It goes beyond diagnostics to guide cardiac care, utilizing specialized ECG analysis to expand access to remote therapeutic monitoring. The platform integrates with third-party FDA-cleared cardiac monitoring devices, including mobile ECG, mobile cardiac telemetry, and implantable cardiac monitors, all accessible from a mobile phone. Designed for clinicians, SafeBeat Rx provides explainable AI and custom tools to display diagnostic information and patient-specific treatment steps, streamlining workflows without overwhelming alerts. Its proprietary machine learning algorithms power solutions from ECG interpretation to treatment management, also offering its software to power other products. The product is currently under development and limited to investigational use only.

Mira, powered by Bharosa AI, is an advanced AI health assistant designed to provide personalized health insights, real-time monitoring, and proactive wellness recommendations. Users can describe their health concerns, and Mira will offer tailored advice. Key features include 24/7 availability, the ability to explain medical terms in simple language, and secure, private handling of health data. Mira works by scheduling a call with the user, calling them back within a minute, and conversing to provide health advice in their chosen language. The platform emphasizes privacy with state-of-the-art encryption.

Fullpower-AI delivers a real-time, science-based AI-biosensing and generative AI SaaS platform, validated by Stanford Sleep Medicine and UCSF. This no-code solution, with optional API configurations, is designed for healthcare, wellness, senior care, and sleep science. The platform monitors over 30 parameters, including breathing rate, AHI, arousal index, heart rate, HRV, and air quality, leveraging over 250 million nights of high-fidelity sleep data. It aims to make advanced AI biosensing universally accessible, empowering better sleep, Remote Patient Monitoring (RPM), and healthspan through continuous, contactless sensing transformed into actionable health intelligence.

IMVARIA is a software-as-medical-device (SaMD) company pioneering AI-driven digital biomarker solutions, primarily focused on lung disease. Their tools, Fibresolve and ScreenDx, are FDA-authorized AI diagnostics for idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD), respectively. Fibresolve provides a diagnostic subtype classification for suspected lung fibrosis, aiding in non-invasive diagnosis and guiding treatment pathways. ScreenDx is a screening algorithm that assesses CT imaging data for findings suggestive of ILD, enhancing referral pathways and early identification. Founded by physician-engineers from Google and Stanford, IMVARIA leverages machine learning and deep-learning models to transform clinical decision-making into data science, aiming to reduce the need for invasive biopsy testing and improve patient outcomes.

MaskFit AR is an AI-powered platform designed to simplify CPAP mask fitting for clinicians and patients. It utilizes advanced AI face scanning technology to recommend the most suitable CPAP/BiPAP mask and size in minutes, eliminating the need for traditional, in-person fitting methods and physical tools. The platform supports all major mask manufacturers, with new models continuously added to ensure up-to-date recommendations. MaskFit AR prioritizes security and patient safety, employing encrypted transmission, secure cloud infrastructure, and strict access controls to comply with HIPAA and other privacy standards. The workflow involves patients scanning their face with a smartphone, the AI measuring facial structure, matching measurements against mask profiles, and recommending the best-fitting options, leading to better comfort, fewer leaks, and improved compliance.

EyeWatch LIVE revolutionizes care standards by offering unparalleled protection against falls, elopements, and intrusions through its AI-enhanced monitoring system. Unlike traditional solutions, EyeWatch LIVE integrates artificial intelligence with human intervention (AI+HI) from licensed nurse-supervised agents. The system strategically places cameras in resident rooms for comprehensive overnight monitoring, detecting unwanted activities like bed exits or unauthorized entry. Upon detection, virtual nurses notify on-site caregivers and can communicate directly with residents via two-way audio, providing reassurance and preventing incidents before they escalate. This dual-action approach ensures immediate response, significantly enhancing resident safety and offering peace of mind to families and care teams.

Analyzr, now known as the G2M Platform, simplifies predictive analytics and machine learning for B2B sales and marketing. It offers a no-code user interface to build machine learning models quickly, focusing on transparency and outcome-focused insights. The platform allows users to aggregate data from various sources, select variables, train models, and gain actionable insights. Key features include secure data handling, cloud-based scalability, and outputs that feed back into native systems. Analyzr supports use cases like clustering, propensity scoring, regression, and A/B testing to help businesses optimize outcomes and improve marketing effectiveness.

Doc AI serves as an AI-powered integrative wellness guide, offering personalized health insights anytime, anywhere. Users can inquire about symptoms, lab reports, natural remedies, essential oils, Ayurvedic practices, and medication options, receiving clear, consolidated responses. The platform is designed to explain complex lab results in simple language and provides 'red-flag' guidance to identify when professional medical care is necessary. It emphasizes privacy, ensuring health conversations remain confidential and are not used for training external AI models. Doc AI offers a structured approach to health intake, remembering user context for follow-up questions, and supports multilingual guidance.

Grand-App AI revolutionizes senior care with its AI-powered platform, SeniorMatics, designed to enhance safety, predict risks, and provide personalized support for elderly individuals. It empowers families and caregivers with real-time insights and actionable care plans, ensuring peace of mind and improved well-being for loved ones. The platform offers predictive, proactive, and preventive care solutions through AI-powered insights, personalized action plans, and real-time alerts. Grand-App AI also provides comprehensive elderly home care services in Florida and tailored senior care for nursing homes, streamlining operations and improving resident care management.

HER Heard is an emerging AI-powered platform dedicated to supporting midlife women facing health challenges. It addresses the common struggle of lacking information and personalized support, which can impact work, relationships, social life, and mental health. The tool is being built to offer tailored assistance, helping women understand their bodies, maximize non-medical lifestyle options, and navigate health decisions. By fostering a community, HER Heard aims to combat isolation and empower women to live their best lives. The platform emphasizes being pro-science and safe, while also respecting individual values for wellness and quality of life. It is currently under development and actively seeking user feedback to shape its features.

AcceXible is an innovative speech analysis platform leveraging advanced AI models to identify various diseases, including dementia, Parkinson's, and coronary disease. This tool provides a rapid, digital, and cost-effective method for both diagnosis and ongoing patient monitoring. By analyzing speech patterns, AcceXible aims to offer early detection capabilities, which can significantly improve patient outcomes and reduce the overall burden on healthcare systems. Its focus on speech as a biomarker makes it a unique and accessible solution for medical professionals seeking efficient diagnostic aids.

Biostate AI is dedicated to redefining precision health by integrating advanced wetlab technologies with biomedical AI. The platform connects biological samples, data, and decisions to enable earlier, data-driven insights for precision medicine. Key offerings include patented technologies like BIRT, PERD, and MARE for high-fidelity RNA and DNA sequencing at significantly lower costs and higher efficiency. These technologies allow for large-scale transcriptomic and genomic data collection, forming the foundation for Biostate's AI-driven disease prediction and drug response models. The company also develops autonomous AI scientists, such as K-Dense, which can generate publication-ready scientific texts and achieve state-of-the-art benchmark performance. Biostate AI operates through a global collaboration network with subsidiaries and joint ventures in the US, China, India, and Saudi Arabia, focusing on population-scale multi-omics and AI-driven health management.

IdentifyX is an AI-driven platform revolutionizing radiology reporting by offering rapid and accurate analysis of MRI, CT, and X-ray scans. Designed for hospitals, diagnostic centers, and radiologists, it streamlines the diagnostic process by allowing effortless scan uploads and generating detailed reports in seconds. The platform leverages advanced algorithms to identify abnormalities and ensures precision diagnoses. Reports undergo a quick verification process by radiologists before dissemination. IdentifyX is committed to continuous innovation, with upcoming features like Auto-Pilot Mode for instant reports, a mobile app for on-the-go access, and voice recognition integration. It aims to empower medical professionals to deliver lightning-fast, accurate diagnoses and enhance patient care worldwide.

INCEPTO offers a comprehensive platform of AI solutions specifically designed for medical imaging, aiming to save time and lives. It provides a curated portfolio of over 30 AI tools tailored for clinical imaging, developed through R&D and partnerships with leading vendors. The platform features AI orchestration for seamless integration, intelligent routing, and accurate result delivery across various infrastructures. A key offering is TANGO, a voice-activated AI assistant for radiology reporting, designed to generate faster, error-free, and organized reports. INCEPTO also emphasizes change management and a patient-centric approach, ensuring successful AI adoption and real clinical value. The platform is compliant with high standards of safety, privacy, and accountability, including CE, FDA, GDPR, HIPAA, ISO 13485, ISO 27001, and C5 certifications.